SurModics, Inc.   Report issue

For profit Phase 1
Founded: Birmingham AL United States (1979)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2005
NCT00915837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SurModics, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Edema (Phase 1)

Macular Edema (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1